Business Description
Yixintang Pharmaceutical Group Co Ltd
ISIN : CNE100001WJ8
Share Class Description:
SZSE:002727: Class ACompare
Compare
Traded in other countries / regions
002727.China IPO Date
2014-07-02Description
Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.04 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | 7.11 | |||||
| Interest Coverage | 4.78 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.2 | |||||
| Beneish M-Score | -3.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | 21.3 | |||||
| 3-Year EPS without NRI Growth Rate | -2.2 | |||||
| 3-Year FCF Growth Rate | 33.4 | |||||
| 3-Year Book Growth Rate | 10.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.68 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.32 | |||||
| 9-Day RSI | 37.79 | |||||
| 14-Day RSI | 42.54 | |||||
| 6-1 Month Momentum % | -12.05 | |||||
| 12-1 Month Momentum % | -38.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 115.91 | |||||
| Days Sales Outstanding | 33.71 | |||||
| Days Payable | 139.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.92 | |||||
| Dividend Payout Ratio | 0.72 | |||||
| 3-Year Dividend Growth Rate | 10.1 | |||||
| Forward Dividend Yield % | 2.92 | |||||
| 5-Year Yield-on-Cost % | 3.65 | |||||
| Shareholder Yield % | 2.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.96 | |||||
| Operating Margin % | 3.95 | |||||
| Net Margin % | 0.86 | |||||
| FCF Margin % | 9.7 | |||||
| ROE % | 2 | |||||
| ROA % | 0.92 | |||||
| ROIC % | 5 | |||||
| ROC (Joel Greenblatt) % | 10.61 | |||||
| ROCE % | 4.54 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 52.83 | |||||
| Forward PE Ratio | 12.41 | |||||
| PE Ratio without NRI | 24.38 | |||||
| Shiller PE Ratio | 12.5 | |||||
| PEG Ratio | 0.98 | |||||
| PS Ratio | 0.44 | |||||
| PB Ratio | 1.06 | |||||
| Price-to-Tangible-Book | 1.48 | |||||
| Price-to-Free-Cash-Flow | 4.64 | |||||
| Price-to-Operating-Cash-Flow | 4.04 | |||||
| EV-to-EBIT | 18.06 | |||||
| EV-to-EBITDA | 18.06 | |||||
| EV-to-Revenue | 0.44 | |||||
| EV-to-FCF | 4.49 | |||||
| Price-to-Projected-FCF | 0.36 | |||||
| Price-to-DCF (Earnings Based) | 1.44 | |||||
| Price-to-DCF (FCF Based) | 0.15 | |||||
| Price-to-Median-PS-Value | 0.3 | |||||
| Price-to-Graham-Number | 1.27 | |||||
| Price-to-Net-Current-Asset-Value | 18.93 | |||||
| Earnings Yield (Greenblatt) % | 5.54 | |||||
| FCF Yield % | 21.94 | |||||
| Forward Rate of Return (Yacktman) % | 16.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yixintang Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 18,156.913 | ||
| EPS (TTM) (Â¥) | 0.258 | ||
| Beta | 1.61 | ||
| Volatility % | 47.7 | ||
| 14-Day RSI | 42.54 | ||
| 14-Day ATR (Â¥) | 0.400112 | ||
| 20-Day SMA (Â¥) | 14.1505 | ||
| 12-1 Month Momentum % | -38.99 | ||
| 52-Week Range (Â¥) | 10.84 - 24.57 | ||
| Shares Outstanding (Mil) | 585.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yixintang Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yixintang Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yixintang Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Yixintang Pharmaceutical Group Co Ltd(SZSE:002727)'s stock price today?
The current price of SZSE:002727 is ¥13.63. The 52 week high of SZSE:002727 is ¥24.57 and 52 week low is ¥10.84.
When is next earnings date of Yixintang Pharmaceutical Group Co Ltd(SZSE:002727)?
The next earnings date of Yixintang Pharmaceutical Group Co Ltd(SZSE:002727) is .
Does Yixintang Pharmaceutical Group Co Ltd(SZSE:002727) pay dividends? If so, how much?
The Dividend Yield %  of Yixintang Pharmaceutical Group Co Ltd(SZSE:002727) is 2.92% (As of Today), Highest Dividend Payout Ratio of Yixintang Pharmaceutical Group Co Ltd(SZSE:002727) was 0.72. The lowest was 0.18. And the median was 0.29. The  Forward Dividend Yield % of Yixintang Pharmaceutical Group Co Ltd(SZSE:002727) is 2.92%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers